BioNTech & Pfizer Test Kids COVID Vaccine
Germany's BioNTech & Pfizer Test COVID Vaccine for Kids
Source: Stock Image of Child & Vaccine
Source: BioNTech & Pfizer
Breakthrough Medical Innovation
Pfizer and its German partner BioNTech hope to be able to vaccinate children under 12 years old against COVID-19 by early 2022. Early stage trials started in late March 2021. The volunteers (via their parents) are as young as 6 months old. The Pfizer BioNTech COVID vaccine for adults was the first authorized for use in the US in mid December 2020 and among the first to hit global markets in late fall 2020. In the US alone, 66 million people have received it.
Shot In The Arm
Only the Pfizer BioNTech vaccine is being used on 16 and 17 year old teens in the US. Moderna's vaccine has been cleared for those 18 years and older. No vaccine has been authorized for use on children under 16 year old in the US. The Pfizer BioNTech vaccine for children is a two shot dosage. In Phase 1 and 2 trials, three different dosage levels - 10, 20 & 30 micrograms - will be used among 144 volunteer participants. The companies plan to expand the test group to 4,500 during Phase 3, where they will test for safety, tolerability, immune response and effectiveness. The COVID vaccines are global medical innovation breakthroughs and are proving to be the critical weapon in the global war against COVID.